Interleukin-8 as a prognostic serum marker in canine mammary gland neoplasias

Veterinary Immunology and Immunopathology

Volumn 146, Issue 2, 2012, Pages 106-112

  Gelaleti, Gabriela Bottaro ^a   Jardim, Bruna Victorasso ^a   Leonel, Camila ^a   Moschetta, Marina Gobbe ^b   Zuccari, Debora Ap Pires de Campos ^a,b  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b FACULDADE DE MEDICINA DE SÃO JOSÉ DO RIO PRETO   (Brazil)

Author keywords

Interleukin 8; Mammary neoplasia; Prognostic factors

Indexed keywords

INTERLEUKIN 8;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST TUMOR; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CLINICAL FEATURE; CONTROLLED STUDY; DOG; ENZYME IMMUNOASSAY; FEMALE; FOLLOW UP; METASTASIS; NONHUMAN; PROGNOSIS; PROTEIN BLOOD LEVEL; TUMOR CELL; TUMOR GROWTH;

ANIMALS; DISEASE PROGRESSION; DOG DISEASES; DOGS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; INTERLEUKIN-8; KAPLAN-MEIER ESTIMATE; MAMMARY NEOPLASMS, ANIMAL; PREDICTIVE VALUE OF TESTS; ROC CURVE; TUMOR MARKERS, BIOLOGICAL;

ANIMALIA; CANIS FAMILIARIS;

EID: 84859502574     PISSN: 01652427     EISSN: 18732534     Source Type: Journal    
DOI: 10.1016/j.vetimm.2012.02.005     Document Type: Article

References (44)

1. Ahmed O.I., Adel A.M., Diab D.R., Gobran N.S. Prognostic value of serum level of interleukin-6 and interleukin-8 in metastatic breast cancer patients. Egypt. J. Immunol. 2006, 13(2):61-68.
2. Almeida J.R.C., Pedrosa N.L., Leite J.B., Fleming T.R.P., Carvalho V.H., Cardoso A.A.A. Marcadores tumorais: revisão de literatura. Rev. Bras. Cancerol. 2007, 53(3):305-316.
3. Balkwill F., Mantovani A. Inflammation and cancer: back to Virchow?. Lancet 2001, 357(9255):539-545.
4. Benoy I.H., Slagado R., Van Dam P., Geboers K., Van Marck E., Scharpe S., Vermeulen P.B., Dirix L.Y. Increased serum interleukin-8 in patients with early and metastatic breast cancer correlates with early dissemination and survival. Clin. Cancer Res. 2004, 10:7157-7162.
5. Bobrovnikova-Marjon E.V., Marjon P.L., Barbash O., Jagt D.L.V., Abcouwer S.F. Expression of angiogenic factors vascular endothelial growth factor and interleukin-8/CXCL8 is highly responsive to ambient glutamine availability. Cancer Res. 2004, 64:4858-4869.
6. Brodey R.S., Goldschmidt M.H., Roszel J.R. Canine mammary gland neoplasms. J. Am. Anim. Hosp. Assoc. 1983, 19:61-89.
7. Cassali G.D., Bertagnolli A.C., Lavalle G.E., Tavares W.L.F., Ferreira E., Silva A.E., Campos C.B. Perspectives for diagnosis, prognosis and treatment of mammary neoplasms in dogs. 34th World Small Animal Veterinary Congress - WSAVA 2009, Proceedings of the 34th World Small Animal Veterinary Congress - WSAVA 2009 2010.
8. Coussens L.M., Werb Z. Inflammation and cancer. Nature 2002, 19(420):860-867.
9. De Larco J.E., Wuertz B.R.K., Yee D., Rickert B.L., Furcht L.T. Atypical methylation of the interleukin-8 gene correlates strongly with the metastatic potential of breast carcinoma cells. Cell Biol. 2003, 24:13988-13993.
10. Derin D., Soydinc H.O., Guney N., Tas F., Camlica H., Duranyildiz D., Yasasever V., Topuz E. Serum IL-8 and IL-12 levels in breast cancer. Med. Oncol. 2007, 24(2):163-168.
11. Harada A., Sekido N., Akahoshi T., Wada T., Mukaida N., Matsushima K. Essential involvement of interleukin-8 (IL-8) in acute inflammation. J. Leukoc. Biol. 1994, 56:559-564.
12. Kim H.S., Park Y.H., Park M.J., Chang M.H., Jun H.J., Kim K.H., Ahn J.S., Kang W.K., Park K., Im Y. Clinical significance of a serum CA15-3 surge and the usefulness of CA15-3 kinetics in monitoring chemotherapy response in patients with metastatic breast cancer. Breast Cancer Res. Treat. 2009, 118(1):89-97.
13. Kozlowski L., Zakrzewska I., Tokajuk P., Wojtukiewicz M.Z. Concentration of interleukin-6 (IL-6), interleukin-8 (IL-8) and interleukin-10 (IL-10) in blood serum of breast cancer patients. Ann. Acad. Med. Bialostocensis 2003, 82-84.
14. Lee L.F., Hellendall R.P., Wang Y., Haskill J.S., Mukaida N., Matsushima K., Ting J.P. IL-8 reduced tumorigenicity of human ovarian cancer in vivo due to neutrophil infiltration. J. Immunol. 2000, 164:2769-2775.
15. Lee H.L., Eom H.S., Yun T., Kim H.J., Park W.S., Nam B.H., Moon-Woo S., Lee D.H., Kong S.Y. Serum and urine levels of interleukin-8 in patients with non-Hodgkin's lymphoma. Cytokine 2008, 43(1):71-75.
16. Leek R.D., Harris A.L., Lewis C.E. Cytokine networks in solid human tumours: regulation of angiogenesis. J. Leukoc. Biol. 1994, 57:423-435.
17. MacEwen E.G. Spontaneous tumors in dogs and cats: models for the study of cancer biology and treatment. Cancer Metastases Rev. 1990, 9(1):125-136.
18. Maurya P., Meleady P., Dowling P., Clynes M. Proteomic approaches for serum biomarker discovery in cancer. Anticancer Res. 2007, 27:1247-1255.
19. Misdorp W., Else R.W., Hellmén E., Lipscomb E. Definitions and Explanatory Notes. Who Histological Classification of Mammary Tumors of the Dog and Cat 1999, Armed Forces Institute of Pathology, Washington, pp. 18-27.
20. Mottollese M., Morelli L., Agrimi U., Benevolo M., Sciarretta F., Antonucci G., Natali G.N. Spontaneous canine mammary tumors - a model for monoclonal antibody diagnosis and treatment of human breast cancer. Lab. Invest. 1994, 71(2):182-187.
21. Nutz S., Doll K., Karlovsky P. Determination of the LOQ in real-time PCR by receiver operating characteristic curve analysis: application to qPCR assays for Fusarium verticillioides and F. proliferatum. Anal. Bioanal. Chem. 2011, 401:717-726.
22. Perez A.M.D.M., Peña L., Del Castilho N., Nieto A.L. Factors influencing the incidence and prognosis of canine mammary tumors. J. Small Anim. Pract. 2000, 41:476-481.
23. Peleteiro M.C. Tumores mamários na cadela e na gata. Revista Portuguesa de Ciênc Veterinárias, LXXXIX 1994, 509:10-29.
24. Queiroga F., Lopes C. Tumores mamários caninos, pesquisa de novos fatores de prognóstico. Revista Portuguesa de Ciências Veterinárias 2002, 97(543):119-127.
25. Richmond A., Thomas H. Purification of melanoma growth stimulatory activity. J. Cell. Physiol. 1986, 129:375-384.
26. Sakao Y., Miyamoto H., Yamazaki A. Prognostic significance of metastasis to the highest mediastinal lymph node in non-small cell lung cancer. Ann. Thorac. Cardiovasc. Surg. 2006, 81(3):292-298.
27. Schneider R. Comparison of age, sex and incidence rates in human and canine breast cancer. Cancer 1970, 26(2):419-426.
28. Shahzad A., Knapp M., Lang I., Kohler G. Interleukin 8 (IL-8) - a universal biomarker?. Int. Arch. Med. 2010, 3-11.
29. Slater, D., 2007. Oncology in reproductive system. In: Manual of Small Animal Surgery, pp. 2439-2444.
30. Sorenmo K. An update on canine mammary gland tumors. Proceedings of the16th Acvim Forum 1998, 387-388.
31. Thomas E., Berner G. Prognostic and predictive implications of HER2 status for breast cancer patients. Eur. J. Oncol. Nurs. 2000, 4:10-17.
32. Van't Veer L.J., Paik S., Hayes D.F. Gene expression profiling of breast cancer: a new tumor marker. J. Clin. Oncol. 2005, 23(8):1631-1635.
33. Wahl L.M., Kleinman H.K. Tumor-associated macrophages as targets for cancer therapy. J. Nat. Cancer Inst. 1998, 90:1583-1584.
34. Waugh D.J.J., Wilson C. The interleukin-8 pathway in cancer. Clin. Cancer Res. 2008, 14:6735-6741.
35. Xie K. Interleukin-8 and human cancer biology. Cytokine Growth Factor Rev. 2001, 12:375-391.
36. Yang Y., Iyers L.K., Adelstein S.J., Kassis A.I. Integrative genomic data mining for discovery of potential blood-borne biomarkers for early diagnosis of cancer. J. PLoS One 2008, 3(11):3661.
37. Yao M., Zhou R., Petreaca M., Zheng Li, Shyy J., Martins-Green M. Activation of sterol regulatory element-binding proteins (SREBPs) is critical in IL-8-induced angiogenesis. J. Leukoc. Biol. 2006, 608-620.
38. Yeon J., Suh Y., Kim S., Baik H., Sung C., Kim H., Sung M. Evaluation of dietary factors in relation to the biomarkers of oxidative stress and inflammation in breast cancer risk. Nutrition 2011, 27(9):912-918.
39. Zhang W., Chen H. The study on the interleukin-8 (IL-8). Sheng Wu Yi Xue Gong Cheng Xue Za Zhj 2002, 19(4):697-702.
40. Zhous S., Wang G., Liu C., Zhou M. Eukaryotic Initiation Factor 4E (eIF4E) and angiogenesis: prognostic markers for breast cancer. BMC Cancer 2006, 1471-2407.
41. Zlotnik A., Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 2000, 12(2):121-127.
42. Zuccari D.A.P.C., Santana A.E., Rocha N.S. Correlação entre a citologia aspirativa por agulha fina e a histologia no diagnóstico de tumores mamários de cadelas. Braz. J. Vet. Res. Anim. Sci. 2001, 38(1):38-41.
43. Zuccari D.A.P.C., Pavam M.V., Terzian A.C.B., Pereira R.S., Ruiz C.M., Andrade J.C. Immunohistochemical evaluation of e-cadherin, Ki-67 and PCNA in canine mammary neoplasias: correlation of prognostic factors and clinical outcome. Pesq. Vet. Bras. 2008, 28(4):207-215.
44. Zuccari D.A.P.C., Castro R., Gelaleti G.B., Mancini U.M. Interleukin-8 expression associated with canine mammary tumors. Genet. Mol. Res. 2011, 10(3):1522-1532.